
Company Number
04528418
Next Accounts
Jun 2026
Shareholders
catalyst healthcare manchester holdings ltd
Group Structure
View All
Industry
Other professional, scientific and technical activities (not including environmental consultancy or quantity surveying) n.e.c.
Registered Address
c/o albany spc services ltd, 3rd floor, manchester, M1 4HB
Website
https://www.scholl.comPomanda estimates the enterprise value of CATALYST HEALTHCARE (MANCHESTER) LIMITED at £82.6m based on a Turnover of £84.9m and 0.97x industry multiple (adjusted for size and gross margin).
Pomanda estimates the enterprise value of CATALYST HEALTHCARE (MANCHESTER) LIMITED at £86.4m based on an EBITDA of £12.4m and a 6.98x industry multiple (adjusted for size and gross margin).
Pomanda estimates the enterprise value of CATALYST HEALTHCARE (MANCHESTER) LIMITED at £0 based on Net Assets of £-4.9m and 2.3x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Catalyst Healthcare (manchester) Limited is a live company located in manchester, M1 4HB with a Companies House number of 04528418. It operates in the other professional, scientific and technical activities n.e.c. sector, SIC Code 74909. Founded in September 2002, it's largest shareholder is catalyst healthcare manchester holdings ltd with a 100% stake. Catalyst Healthcare (manchester) Limited is a mature, large sized company, Pomanda has estimated its turnover at £84.9m with healthy growth in recent years.
Pomanda's financial health check has awarded Catalyst Healthcare (Manchester) Limited a 5 rating. We use a traffic light system to show it exceeds the industry average on 6 measures and has 2 areas for improvement. Company Health Check FAQs
6 Strong
2 Regular
2 Weak
Size
annual sales of £84.9m, make it larger than the average company (£2.3m)
£84.9m - Catalyst Healthcare (manchester) Limited
£2.3m - Industry AVG
Growth
3 year (CAGR) sales growth of 12%, show it is growing at a similar rate (10.4%)
12% - Catalyst Healthcare (manchester) Limited
10.4% - Industry AVG
Production
with a gross margin of 19.7%, this company has a higher cost of product (46%)
19.7% - Catalyst Healthcare (manchester) Limited
46% - Industry AVG
Profitability
an operating margin of 14.6% make it more profitable than the average company (5.4%)
14.6% - Catalyst Healthcare (manchester) Limited
5.4% - Industry AVG
Employees
with 709 employees, this is above the industry average (19)
- Catalyst Healthcare (manchester) Limited
19 - Industry AVG
Pay Structure
There is insufficient data available for this Key Performance Indicator!
- Catalyst Healthcare (manchester) Limited
- - Industry AVG
Efficiency
resulting in sales per employee of £119.8k, this is equally as efficient (£119.9k)
- Catalyst Healthcare (manchester) Limited
£119.9k - Industry AVG
Debtor Days
it gets paid by customers after 28 days, this is earlier than average (53 days)
28 days - Catalyst Healthcare (manchester) Limited
53 days - Industry AVG
Creditor Days
its suppliers are paid after 41 days, this is slower than average (31 days)
41 days - Catalyst Healthcare (manchester) Limited
31 days - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- - Catalyst Healthcare (manchester) Limited
- - Industry AVG
Cash Balance
has cash to cover current liabilities for 52 weeks, this is more cash available to meet short term requirements (26 weeks)
52 weeks - Catalyst Healthcare (manchester) Limited
26 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 100.8%, this is a higher level of debt than the average (52.8%)
100.8% - Catalyst Healthcare (manchester) Limited
52.8% - Industry AVG
Catalyst Healthcare (Manchester) Limited's latest turnover from September 2024 is £84.9 million and the company has net assets of -£4.9 million. According to their latest financial statements, we estimate that Catalyst Healthcare (Manchester) Limited has 709 employees and maintains cash reserves of £44.6 million as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
Sep 2024 | Sep 2023 | Sep 2022 | Sep 2021 | Sep 2020 | Sep 2019 | Sep 2018 | Sep 2017 | Sep 2016 | Sep 2015 | Sep 2014 | Sep 2013 | Sep 2012 | Sep 2011 | Sep 2010 | Sep 2009 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Turnover | 84,940,000 | 71,277,000 | 75,263,000 | 60,879,000 | 63,015,000 | 60,633,000 | 58,438,000 | 55,354,000 | 50,753,000 | 52,412,000 | 55,363,000 | 54,985,000 | 58,643,000 | 43,029,000 | 45,463,000 | 114,950,000 |
Other Income Or Grants | ||||||||||||||||
Cost Of Sales | 68,247,000 | 57,603,000 | 62,483,000 | 51,584,000 | 54,001,000 | 50,941,000 | 49,008,000 | 46,818,000 | 43,856,000 | |||||||
Gross Profit | 16,693,000 | 13,674,000 | 12,780,000 | 9,295,000 | 9,014,000 | 9,692,000 | 9,430,000 | 8,536,000 | 6,897,000 | |||||||
Admin Expenses | 4,320,000 | 3,846,000 | 3,757,000 | 3,908,000 | 4,489,000 | 4,868,000 | 4,034,000 | 3,415,000 | 3,736,000 | |||||||
Operating Profit | 12,373,000 | 9,828,000 | 9,023,000 | 5,387,000 | 4,525,000 | 4,824,000 | 5,396,000 | 5,121,000 | 3,161,000 | -1,936,000 | 5,451,000 | 4,841,000 | 4,031,000 | 3,881,000 | 1,664,000 | 14,966,000 |
Interest Payable | 50,254,000 | 86,287,000 | 55,793,000 | 26,350,000 | 34,257,000 | 33,399,000 | 37,363,000 | 30,239,000 | 25,109,000 | 23,527,000 | 31,187,000 | 33,331,000 | 35,953,000 | 40,239,000 | 34,110,000 | 17,549,000 |
Interest Receivable | 33,039,000 | 31,695,000 | 32,110,000 | 30,670,000 | 31,453,000 | 32,121,000 | 32,368,000 | 32,741,000 | 33,181,000 | 33,514,000 | 33,856,000 | 34,309,000 | 34,708,000 | 34,777,000 | 34,798,000 | 20,657,000 |
Pre-Tax Profit | -4,842,000 | -44,764,000 | -14,660,000 | 9,707,000 | 1,721,000 | 3,546,000 | 401,000 | 7,623,000 | 11,236,000 | 8,051,000 | 8,120,000 | 5,819,000 | 2,786,000 | -1,581,000 | 2,352,000 | 18,074,000 |
Tax | -5,000 | 1,844,000 | -1,844,000 | -327,000 | -674,000 | -76,000 | -1,486,000 | -2,247,000 | -1,657,000 | -1,797,000 | -1,368,000 | -696,000 | 444,000 | -661,000 | -5,062,000 | |
Profit After Tax | -4,842,000 | -44,769,000 | -12,816,000 | 7,863,000 | 1,394,000 | 2,872,000 | 325,000 | 6,137,000 | 8,989,000 | 6,394,000 | 6,323,000 | 4,451,000 | 2,090,000 | -1,137,000 | 1,691,000 | 13,012,000 |
Dividends Paid | 329,000 | 386,000 | 1,032,000 | 514,000 | 6,151,000 | |||||||||||
Retained Profit | -4,842,000 | -44,769,000 | -12,816,000 | 7,863,000 | 1,394,000 | 2,872,000 | 325,000 | 6,137,000 | 8,989,000 | 6,394,000 | 5,994,000 | 4,065,000 | 1,058,000 | -1,651,000 | -4,460,000 | 13,012,000 |
Employee Costs | ||||||||||||||||
Number Of Employees | ||||||||||||||||
EBITDA* | 12,373,000 | 9,828,000 | 9,023,000 | 5,387,000 | 4,525,000 | 4,824,000 | 5,396,000 | 5,121,000 | 3,161,000 | -1,936,000 | 5,451,000 | 4,841,000 | 4,031,000 | 3,881,000 | 1,664,000 | 14,966,000 |
* Earnings Before Interest, Tax, Depreciation and Amortisation
Sep 2024 | Sep 2023 | Sep 2022 | Sep 2021 | Sep 2020 | Sep 2019 | Sep 2018 | Sep 2017 | Sep 2016 | Sep 2015 | Sep 2014 | Sep 2013 | Sep 2012 | Sep 2011 | Sep 2010 | Sep 2009 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Tangible Assets | ||||||||||||||||
Intangible Assets | ||||||||||||||||
Investments & Other | ||||||||||||||||
Debtors (Due After 1 year) | 358,997,000 | 368,590,000 | 377,473,000 | 385,698,000 | 393,314,000 | 401,836,000 | 409,753,000 | 417,613,000 | 424,155,000 | 431,293,000 | 428,484,000 | 432,927,000 | 437,041,000 | 440,851,000 | 443,868,000 | 445,456,000 |
Total Fixed Assets | 358,997,000 | 368,590,000 | 377,473,000 | 385,698,000 | 393,314,000 | 401,836,000 | 409,753,000 | 417,613,000 | 424,155,000 | 431,293,000 | 428,484,000 | 432,927,000 | 437,041,000 | 440,851,000 | 443,868,000 | 445,456,000 |
Stock & work in progress | ||||||||||||||||
Trade Debtors | 6,531,000 | 11,314,000 | 2,449,000 | 5,554,000 | 5,944,000 | 3,915,000 | 2,385,000 | 2,792,000 | 1,610,000 | 9,851,000 | 6,096,000 | 5,297,000 | 24,525,000 | 11,950,000 | 18,388,000 | 13,022,000 |
Group Debtors | ||||||||||||||||
Misc Debtors | 139,750,000 | 134,089,000 | 127,404,000 | 115,384,000 | 107,838,000 | 98,735,000 | 89,592,000 | 78,755,000 | 68,565,000 | 62,317,000 | 44,752,000 | 32,397,000 | ||||
Cash | 44,603,000 | 65,595,000 | 54,193,000 | 45,069,000 | 57,879,000 | 55,488,000 | 47,047,000 | 42,640,000 | 37,201,000 | 37,732,000 | 32,121,000 | 34,627,000 | 29,146,000 | 25,278,000 | 25,321,000 | 43,439,000 |
misc current assets | 37,250,000 | |||||||||||||||
total current assets | 228,134,000 | 210,998,000 | 184,046,000 | 166,007,000 | 171,661,000 | 158,138,000 | 139,024,000 | 124,187,000 | 107,376,000 | 109,900,000 | 82,969,000 | 72,321,000 | 53,671,000 | 37,228,000 | 43,709,000 | 56,461,000 |
total assets | 587,131,000 | 579,588,000 | 561,519,000 | 551,705,000 | 564,975,000 | 559,974,000 | 548,777,000 | 541,800,000 | 531,531,000 | 541,193,000 | 511,453,000 | 505,248,000 | 490,712,000 | 478,079,000 | 487,577,000 | 501,917,000 |
Bank overdraft | ||||||||||||||||
Bank loan | ||||||||||||||||
Trade Creditors | 7,724,000 | 9,579,000 | 4,899,000 | 11,561,000 | 6,674,000 | 5,999,000 | 1,728,000 | 4,598,000 | 2,599,000 | 12,142,000 | 6,266,000 | 5,531,000 | 4,074,000 | 3,651,000 | 14,043,000 | 10,244,000 |
Group/Directors Accounts | 16,174,000 | 17,683,000 | 16,815,000 | 19,575,000 | 20,421,000 | 28,692,000 | 22,573,000 | 16,175,000 | 16,619,000 | 13,654,000 | 13,891,000 | 12,758,000 | 11,965,000 | 12,372,000 | 11,866,000 | 20,679,000 |
other short term finances | ||||||||||||||||
hp & lease commitments | ||||||||||||||||
other current liabilities | 20,213,000 | 17,710,000 | 14,214,000 | 7,493,000 | 9,239,000 | 4,890,000 | 3,640,000 | 5,302,000 | 5,453,000 | 3,734,000 | 2,591,000 | 5,543,000 | 3,395,000 | 2,098,000 | 14,732,000 | 27,614,000 |
total current liabilities | 44,111,000 | 44,972,000 | 35,928,000 | 38,629,000 | 36,334,000 | 39,581,000 | 27,941,000 | 26,075,000 | 24,671,000 | 29,530,000 | 22,748,000 | 23,832,000 | 19,434,000 | 18,121,000 | 40,641,000 | 58,537,000 |
loans | 517,304,000 | 503,573,000 | 452,608,000 | 428,565,000 | 450,400,000 | 441,526,000 | 442,934,000 | 437,860,000 | 435,198,000 | 445,568,000 | 449,645,000 | 449,900,000 | 447,140,000 | 440,793,000 | 429,772,000 | 424,865,000 |
hp & lease commitments | ||||||||||||||||
Accruals and Deferred Income | ||||||||||||||||
other liabilities | ||||||||||||||||
provisions | 30,648,000 | 31,133,000 | 28,304,000 | 27,016,000 | 28,609,000 | 30,629,000 | 32,536,000 | 32,824,000 | 32,758,000 | 36,180,000 | 15,539,000 | 13,989,000 | 10,676,000 | 6,761,000 | 3,109,000 | |
total long term liabilities | 547,952,000 | 534,706,000 | 480,912,000 | 455,581,000 | 479,009,000 | 472,155,000 | 475,470,000 | 470,684,000 | 467,956,000 | 481,748,000 | 465,184,000 | 463,889,000 | 457,816,000 | 447,554,000 | 432,881,000 | 424,865,000 |
total liabilities | 592,063,000 | 579,678,000 | 516,840,000 | 494,210,000 | 515,343,000 | 511,736,000 | 503,411,000 | 496,759,000 | 492,627,000 | 511,278,000 | 487,932,000 | 487,721,000 | 477,250,000 | 465,675,000 | 473,522,000 | 483,402,000 |
net assets | -4,932,000 | -90,000 | 44,679,000 | 57,495,000 | 49,632,000 | 48,238,000 | 45,366,000 | 45,041,000 | 38,904,000 | 29,915,000 | 23,521,000 | 17,527,000 | 13,462,000 | 12,404,000 | 14,055,000 | 18,515,000 |
total shareholders funds | -4,932,000 | -90,000 | 44,679,000 | 57,495,000 | 49,632,000 | 48,238,000 | 45,366,000 | 45,041,000 | 38,904,000 | 29,915,000 | 23,521,000 | 17,527,000 | 13,462,000 | 12,404,000 | 14,055,000 | 18,515,000 |
Sep 2024 | Sep 2023 | Sep 2022 | Sep 2021 | Sep 2020 | Sep 2019 | Sep 2018 | Sep 2017 | Sep 2016 | Sep 2015 | Sep 2014 | Sep 2013 | Sep 2012 | Sep 2011 | Sep 2010 | Sep 2009 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Activities | ||||||||||||||||
Operating Profit | 12,373,000 | 9,828,000 | 9,023,000 | 5,387,000 | 4,525,000 | 4,824,000 | 5,396,000 | 5,121,000 | 3,161,000 | -1,936,000 | 5,451,000 | 4,841,000 | 4,031,000 | 3,881,000 | 1,664,000 | 14,966,000 |
Depreciation | ||||||||||||||||
Amortisation | ||||||||||||||||
Tax | -5,000 | 1,844,000 | -1,844,000 | -327,000 | -674,000 | -76,000 | -1,486,000 | -2,247,000 | -1,657,000 | -1,797,000 | -1,368,000 | -696,000 | 444,000 | -661,000 | -5,062,000 | |
Stock | ||||||||||||||||
Debtors | -8,715,000 | 6,667,000 | 690,000 | -460,000 | 2,610,000 | 2,756,000 | 2,570,000 | 4,830,000 | -9,131,000 | 24,129,000 | 8,711,000 | 9,055,000 | 8,765,000 | -9,455,000 | 3,778,000 | 458,478,000 |
Creditors | -1,855,000 | 4,680,000 | -6,662,000 | 4,887,000 | 675,000 | 4,271,000 | -2,870,000 | 1,999,000 | -9,543,000 | 5,876,000 | 735,000 | 1,457,000 | 423,000 | -10,392,000 | 3,799,000 | 10,244,000 |
Accruals and Deferred Income | 2,503,000 | 3,496,000 | 6,721,000 | -1,746,000 | 4,349,000 | 1,250,000 | -1,662,000 | -151,000 | 1,719,000 | 1,143,000 | -2,952,000 | 2,148,000 | 1,297,000 | -12,634,000 | -12,882,000 | 27,614,000 |
Deferred Taxes & Provisions | -485,000 | 2,829,000 | 1,288,000 | -1,593,000 | -2,020,000 | -1,907,000 | -288,000 | 66,000 | -3,422,000 | 20,641,000 | 1,550,000 | 3,313,000 | 3,915,000 | 3,652,000 | 3,109,000 | |
Cash flow from operations | 21,251,000 | 14,161,000 | 11,524,000 | 5,551,000 | 4,592,000 | 5,008,000 | -2,070,000 | 719,000 | -1,201,000 | -62,000 | -5,724,000 | 1,336,000 | 205,000 | -5,594,000 | -8,749,000 | -410,716,000 |
Investing Activities | ||||||||||||||||
capital expenditure | ||||||||||||||||
Change in Investments | ||||||||||||||||
cash flow from investments | ||||||||||||||||
Financing Activities | ||||||||||||||||
Bank loans | ||||||||||||||||
Group/Directors Accounts | -1,509,000 | 868,000 | -2,760,000 | -846,000 | -8,271,000 | 6,119,000 | 6,398,000 | -444,000 | 2,965,000 | -237,000 | 1,133,000 | 793,000 | -407,000 | 506,000 | -8,813,000 | 20,679,000 |
Other Short Term Loans | ||||||||||||||||
Long term loans | 13,731,000 | 50,965,000 | 24,043,000 | -21,835,000 | 8,874,000 | -1,408,000 | 5,074,000 | 2,662,000 | -10,370,000 | -4,077,000 | -255,000 | 2,760,000 | 6,347,000 | 11,021,000 | 4,907,000 | 424,865,000 |
Hire Purchase and Lease Commitments | ||||||||||||||||
other long term liabilities | ||||||||||||||||
share issue | ||||||||||||||||
interest | -17,215,000 | -54,592,000 | -23,683,000 | 4,320,000 | -2,804,000 | -1,278,000 | -4,995,000 | 2,502,000 | 8,072,000 | 9,987,000 | 2,669,000 | 978,000 | -1,245,000 | -5,462,000 | 688,000 | 3,108,000 |
cash flow from financing | -4,993,000 | -2,759,000 | -2,400,000 | -18,361,000 | -2,201,000 | 3,433,000 | 6,477,000 | 4,720,000 | 667,000 | 5,673,000 | 3,547,000 | 4,531,000 | 4,695,000 | 6,065,000 | -3,218,000 | 454,155,000 |
cash and cash equivalents | ||||||||||||||||
cash | -20,992,000 | 11,402,000 | 9,124,000 | -12,810,000 | 2,391,000 | 8,441,000 | 4,407,000 | 5,439,000 | -531,000 | 5,611,000 | -2,506,000 | 5,481,000 | 3,868,000 | -43,000 | -18,118,000 | 43,439,000 |
overdraft | ||||||||||||||||
change in cash | -20,992,000 | 11,402,000 | 9,124,000 | -12,810,000 | 2,391,000 | 8,441,000 | 4,407,000 | 5,439,000 | -531,000 | 5,611,000 | -2,506,000 | 5,481,000 | 3,868,000 | -43,000 | -18,118,000 | 43,439,000 |
Perform a competitor analysis for catalyst healthcare (manchester) limited by selecting its closest rivals, whether from the PROFESSIONAL, SCIENTIFIC AND TECHNICAL ACTIVITIES sector, other large companies, companies in M 1 area or any other competitors across 12 key performance metrics.
CATALYST HEALTHCARE (MANCHESTER) LIMITED group structure
Catalyst Healthcare (Manchester) Limited has no subsidiary companies.
Ultimate parent company
CIVIS PFI/PPP INFRASTRUCTURE MANCHESTER
#0134878
2 parents
CATALYST HEALTHCARE (MANCHESTER) LIMITED
04528418
Catalyst Healthcare (Manchester) Limited currently has 7 directors. The longest serving directors include Mr Jonathan Cowdell (Nov 2012) and Mr Barry Millsom (Sep 2014).
officer | country | age | start | end | role |
---|---|---|---|---|---|
Mr Jonathan Cowdell | England | 58 years | Nov 2012 | - | Director |
Mr Barry Millsom | England | 50 years | Sep 2014 | - | Director |
Mr Alastair Page | United Kingdom | 63 years | May 2016 | - | Director |
Mr Steven Prior | 52 years | Feb 2017 | - | Director | |
Ms Stephanie Exell | United Kingdom | 47 years | Sep 2019 | - | Director |
Ms Stephanie Exell | England | 46 years | Sep 2019 | - | Director |
Ms Katherine Morgan | England | 51 years | Sep 2022 | - | Director |
P&L
September 2024turnover
84.9m
+19%
operating profit
12.4m
+26%
gross margin
19.7%
+2.44%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
September 2024net assets
-4.9m
+53.8%
total assets
587.1m
+0.01%
cash
44.6m
-0.32%
net assets
Total assets minus all liabilities
company number
04528418
Type
Private limited with Share Capital
industry
74909 - Other professional, scientific and technical activities (not including environmental consultancy or quantity surveying) n.e.c.
incorporation date
September 2002
age
23
incorporated
UK
ultimate parent company
accounts
Full Accounts
last accounts submitted
September 2024
previous names
broomco (3027) limited (December 2002)
accountant
-
auditor
JOHNSTON CARMICHAEL LLP
address
c/o albany spc services ltd, 3rd floor, manchester, M1 4HB
Bank
BANK OF SCOTLAND
Legal Advisor
DLA PIPER UK LLP
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We found 5 charges/mortgages relating to catalyst healthcare (manchester) limited. Currently there are 4 open charges and 1 have been satisfied in the past.
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for CATALYST HEALTHCARE (MANCHESTER) LIMITED. This can take several minutes, an email will notify you when this has completed.
date | description | view/download |
---|